Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Maitreya Medicare's Enterprise Value is ₹937.46 Mil.
Maitreya Medicare's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-188.00 Mil. Therefore, Maitreya Medicare's EV-to-FCF for today is -4.99.
The historical rank and industry rank for Maitreya Medicare's EV-to-FCF or its related term are showing as below:
NSE:MAITREYA'
s EV-to-FCF Range Over the Past 10 Years
Min: -4.99 Med: 64.98 Max: 173.96
Current: -4.99
During the past 5 years, the highest EV-to-FCF of Maitreya Medicare was 173.96. The lowest was -4.99. And the median was 64.98.
NSE:MAITREYA's EV-to-FCF is ranked worse than 100% of 423
companies
in the Healthcare Providers & Services industry
Industry Median: 17
vs NSE:MAITREYA: -4.99
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Maitreya Medicare's PE Ratio (TTM) for today is calculated as:
Maitreya Medicare's share price for today is ₹116.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Maitreya Medicare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-3.640.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Maitreya Medicare EV-to-FCF Related Terms
Maitreya Medicare EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Maitreya Medicare's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:MAITREYA vs HCA, DVA, THC: EV-to-FCF Comparison
For the Medical Care Facilities subindustry, Maitreya Medicare's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Maitreya Medicare EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Maitreya Medicare's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Maitreya Medicare's EV-to-FCF falls into.
Maitreya Medicare's current Enterprise Value is ₹937.46 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Maitreya Medicare's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-188.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Maitreya Medicare (NSE:MAITREYA) has a EV-to-FCF of -4.99 as of Sep. 15, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Maitreya Medicare and its competitors. According to the industry distribution chart, Maitreya Medicare ranks #999999 out of 423 companies in the Healthcare Providers & Services industry.
Is Maitreya Medicare's EV-to-FCF too high?
Maitreya Medicare's current EV-to-FCF is -4.99. Based on the distribution chart, Maitreya Medicare ranks #999999 out of 423 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Maitreya Medicare has a GF Score™ of 26/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Maitreya Medicare's EV-to-FCF compare to HCA and DVA?
According to the Healthcare Providers & Services industry distribution chart, Maitreya Medicare ranks #999999 out of 423 companies for EV-to-FCF. This places Maitreya Medicare in the lower half of its industry. The industry median EV-to-FCF is 17.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 17.00, based on 423 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Maitreya Medicare and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 17.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Maitreya Medicare's current EV-to-FCF is -4.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maitreya Medicare stock overvalued right now?
Based on GuruFocus' analysis, Maitreya Medicare (NSE:MAITREYA) is currently considered Possible Value Trap. The stock's GF Value™ is ₹459.87, compared to a current price of ₹116.00 — trading 74.8% below its estimated fair value. The current EV-to-FCF is -4.99. Maitreya Medicare's overall GF Score™ is 26/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Maitreya Medicare (NSE:MAITREYA), the current EV-to-FCF is -4.99 as of Sep. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Maitreya Medicare (NSE:MAITREYA) Overvalued in 2026?
Based on GuruFocus' analysis, Maitreya Medicare stock appears to be undervalued.
The current stock price of ₹116.00 is trading 74.8% below its estimated GF Value™ of ₹459.87.
GuruFocus considers Maitreya Medicare to be Possible Value Trap.
Key valuation signals for NSE:MAITREYA:
EV-to-FCF: -4.99
GF Value™: ₹459.87 vs. price of ₹116.00 (74.8% below fair value)
No single metric tells the full story. See the NSE:MAITREYA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Maitreya Medicare Ltd is Multi Superspeciality hospital. It is a 125 bedded hospital that provides multi-disciplinary integrated healthcare services, with a focus on primary secondary & tertiary care, and also offers a comprehensive range of healthcare services across over 18 specialties and super specialties, including Cardiology, Urology, Oncology, Laparoscopic Surgery, Neurology, Neurosurgery, Spine Surgery, Nephrology including Dialysis, Gastroenterology, Gastrointestinal surgery, Cardiothoracic Surgery, Oncosurgery, Orthopedic Surgery including joint replacements and Arthroscopic surgeries, Gynecology & High-Risk Obstetrics, Hepatocellular Billary Surgery, Critical Care Medicine etc.
26GF Score
Get the complete analysis for NSE:MAITREYA
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MAITREYA has been successfully added to your 
